Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
MarineMax Inc is a specialty retail business based in the US. MarineMax shares (HZO) are listed on the NYSE and all prices are listed in US Dollars. MarineMax employs 2,666 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $36.83 |
|---|---|
| 52-week range | $35.10 - $61.06 |
| 50-day moving average | $40.26 |
| 200-day moving average | $47.12 |
| Wall St. target price | $52.43 |
| PE ratio | 4.6327 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $7.95 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $36.83 from 2022-07-01
| 1 week (2022-06-29) | -0.91% |
|---|---|
| 1 month (2022-06-03) | -9.08% |
| 3 months (2022-04-05) | -7.21% |
| 6 months (2022-01-06) | -36.50% |
| 1 year (2021-07-06) | -21.75% |
|---|---|
| 2 years (2020-07-06) | 53.71% |
| 3 years (2019-07-05) | 118.84% |
| 5 years (2017-07-06) | 89.85% |
Valuing MarineMax stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MarineMax's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MarineMax's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, MarineMax shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
MarineMax's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.62. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MarineMax's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MarineMax's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $262.8 million.
The EBITDA is a measure of a MarineMax's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.2 billion |
|---|---|
| Operating margin TTM | 11.1% |
| Gross profit TTM | $659.4 million |
| Return on assets TTM | 14.39% |
| Return on equity TTM | 30.38% |
| Profit margin | 8.23% |
| Book value | $31.19 |
| Market capitalisation | $793 million |
TTM: trailing 12 months
We're not expecting MarineMax to pay a dividend over the next 12 months.
Over the last 12 months, MarineMax's shares have ranged in value from as little as $35.1 up to $61.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MarineMax's is 1.6007. This would suggest that MarineMax's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
MarineMax, Inc. operates as a recreational boat and yacht retailer and superyacht services company in the United States. It operates through two segments, Retail Operations and Product Manufacturing. The company sells new and used recreational boats, including pleasure and fishing boats, mega-yachts, yachts, sport cruisers, motor yachts, pontoon boats, ski boats, jet boats, and other recreational boats. It also offers marine parts and accessories comprising marine electronics; dock and anchoring products that include boat fenders, lines, and anchors; boat covers; trailer parts; water sport accessories, which comprise tubes, lines, wakeboards, and skis; engine parts; oils; lubricants; steering and control systems; corrosion control products and service products; high-performance accessories, including propellers and instruments; and a line of boating accessories, such as life jackets, inflatables, and water sports equipment. In addition, the company provides novelty items, such as shirts, caps, and license plates; marine engines and equipment; maintenance, repair, and slip and storage accommodation services; and boat or yacht brokerage services, as well as charters yachts and power catamarans. Further, it offers new or used boat finance services; arranges insurance coverage, including boat property, disability, undercoating, gel sealant, fabric protection, and casualty insurance coverage; and manufactures and sells sport yachts and yachts.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.